603207 小方制药
已收盘 10-31 15:00:00
资讯
新帖
简况
股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%
证券之星 · 10-26
股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%
每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少
证券之星 · 10-25
每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少
小方制药:10月10日高管蒋昶增持股份合计500股
证券之星 · 10-20
小方制药:10月10日高管蒋昶增持股份合计500股
每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)
证券之星 · 10-11
每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)
小方制药闲置募集资金现金管理产品全部到期赎回
中金财经 · 10-11
小方制药闲置募集资金现金管理产品全部到期赎回
小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%
证券之星 · 10-10
小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%
小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)
智通财经 · 09-25
小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)
每周股票复盘:小方制药(603207)布局创新药并拓展境外市场
证券之星 · 09-13
每周股票复盘:小方制药(603207)布局创新药并拓展境外市场
小方制药:9月12日召开业绩说明会
证券之星 · 09-12
小方制药:9月12日召开业绩说明会
每周股票复盘:小方制药(603207)将召开2025年半年度业绩说明会
证券之星 · 09-06
每周股票复盘:小方制药(603207)将召开2025年半年度业绩说明会
小方制药:9月12日将召开2025年半年度业绩说明会
证券日报网 · 09-04
小方制药:9月12日将召开2025年半年度业绩说明会
每周股票复盘:小方制药(603207)中期分红比例达93.02%
证券之星 · 08-31
每周股票复盘:小方制药(603207)中期分红比例达93.02%
小方制药(603207.SH)发布半年度业绩,归母净利润1.21亿元,同比增长1.69%
智通财经 · 08-25
小方制药(603207.SH)发布半年度业绩,归母净利润1.21亿元,同比增长1.69%
小方制药(603207)6月30日股东户数1.48万户,较上期减少22.41%
证券之星 · 08-25
小方制药(603207)6月30日股东户数1.48万户,较上期减少22.41%
每周股票复盘:小方制药(603207)1440万股限售股将于8月26日上市流通
证券之星 · 08-24
每周股票复盘:小方制药(603207)1440万股限售股将于8月26日上市流通
每周股票复盘:小方制药(603207)因日换手率达20%三度上榜
证券之星 · 08-09
每周股票复盘:小方制药(603207)因日换手率达20%三度上榜
小方制药:产品品类丰富剂型全面销售网络覆盖广泛
互动易 · 08-06
小方制药:产品品类丰富剂型全面销售网络覆盖广泛
小方制药:炉甘石洗剂对蚊虫叮咬瘙痒有一定抑制作用
证券之星 · 08-06
小方制药:炉甘石洗剂对蚊虫叮咬瘙痒有一定抑制作用
小方制药:持续强化自主研发能力并与CRO机构战略合作
证券之星 · 08-06
小方制药:持续强化自主研发能力并与CRO机构战略合作
8月4日小方制药(603207)龙虎榜数据:机构净买入1773.64万元
证券之星 · 08-04
8月4日小方制药(603207)龙虎榜数据:机构净买入1773.64万元
加载更多
公司概况
公司名称:
上海小方制药股份有限公司
所属行业:
医药制造业
上市日期:
2024-08-26
主营业务:
上海小方制药股份有限公司的主营业务是外用药的研发、生产和销售。公司的主要产品是开塞露、甘油灌肠剂、炉甘石洗剂、氧化锌软膏、水杨酸软膏、硫软膏、解痉镇痛酊、冻疮膏、复方薄荷脑软膏、尿素维E乳膏、硼酸洗液、苯扎溴铵溶液、苯扎溴铵酊、复方醋酸地塞米松乳膏、复方苦参水杨酸散、白花油、酮康唑乳膏、复方土槿皮酊。
发行价格:
12.47
{"stockData":{"symbol":"603207","market":"SH","secType":"STK","nameCN":"小方制药","latestPrice":32.35,"timestamp":1761894001000,"preClose":31.77,"halted":0,"volume":1608829,"delay":0,"changeRate":0.0183,"floatShares":54400000,"shares":161000000,"eps":1.3297,"marketStatus":"已收盘","change":0.58,"latestTime":"10-31 15:00:00","open":31.77,"high":32.4,"low":31.63,"amount":51751700,"amplitude":0.0242,"askPrice":32.35,"askSize":41,"bidPrice":32.33,"bidSize":3,"shortable":0,"etf":0,"ttmEps":1.3297,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":31.77,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":34.95,"lowLimit":28.59,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":160559967,"isCdr":false,"pbRate":4.93,"roa":"--","peRate":24.328796,"roe":"14.15%","epsLYR":1.53,"committee":-0.421053,"marketValue":5194000000,"turnoverRate":0.0296,"status":0,"floatMarketCap":1760000000},"requestUrl":"/m/hq/s/603207","defaultTab":"news","newsList":[{"id":"2578668105","title":"股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578668105","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578668105?lang=zh_cn&edition=full","pubTime":"2025-10-27 06:17","pubTimestamp":1761517031,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,小方制药报收于32.13元,上涨0.16%,换手率1.73%,成交量9421.0手,成交额3041.95万元。股本股东变化股东户数变动近日小方制药披露,截至2025年9月30日公司股东户数为1.34万户,较9月19日减少138.0户,减幅为1.02%。- 归属于上市公司股东的所有者权益:本报告期末1,054,095,400.88元,较年度末下降14.60%。公司公告汇总2025年第三季度报告报告期末普通股股东总数为13,356户,表决权恢复的优先股股东总数为0户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2578500451","title":"每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2578500451","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578500451?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:40","pubTimestamp":1761424818,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,小方制药报收于32.13元,较上周的33.48元下跌4.03%。股本股东变化高管增减持2025年10月10日,公司董事蒋昶增持公司股份500.0股,占公司总股本的0.0003%。当日公司股价收盘报33.59元,变动期间股价下跌0.3%。股东户数变动截至2025年9月30日,公司股东户数为1.34万户,较9月19日减少138户,减幅为1.02%。运佳远东有限公司持股58.59%,为第一大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2576859051","title":"小方制药:10月10日高管蒋昶增持股份合计500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859051","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576859051?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:13","pubTimestamp":1760962433,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月20日市场公开信息、上市公司公告及交易所披露数据整理,小方制药最新董监高及相关人员股份变动情况:2025年10月10日公司董事蒋昶共增持公司股份500.0股,占公司总股本为0.0003%。变动期间公司股价下跌0.3%,10月10日当日收盘报33.59元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000028728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2574680294","title":"每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574680294","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574680294?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:40","pubTimestamp":1760211625,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,小方制药报收于33.59元,较上周的33.73元下跌0.42%。本周,小方制药10月9日盘中最高价报33.88元。本周关注点公司公告汇总:小方制药2025年半年度权益分派方案公布,每股派发现金红利0.70元(含税)。本次利润分配以公司总股本160,559,967股为基数,共派发现金红利112,391,976.90元。分配对象为截至股权登记日在中国结算上海分公司登记在册的全体A股股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2574481585","title":"小方制药闲置募集资金现金管理产品全部到期赎回","url":"https://stock-news.laohu8.com/highlight/detail?id=2574481585","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574481585?lang=zh_cn&edition=full","pubTime":"2025-10-11 08:29","pubTimestamp":1760142554,"startTime":"0","endTime":"0","summary":"中访网数据 上海小方制药股份有限公司发布公告,其使用闲置募集资金进行现金管理的相关产品已全部到期赎回,本金及收益均已归还至募集资金专户。公告披露了具体赎回情况,涉及上海浦东发展银行、中国工商银行和招商银行的多笔定期存款及通知存款产品,累计赎回本金达3.03亿元人民币,并获得相应投资收益。公司此前经董事会和监事会审议批准,使用不超过2亿元人民币的闲置募集资金进行现金管理,投资于安全性高、流动性好的银行存款类产品。截至公告日,公司使用闲置募集资金购买理财产品的余额为零,所有操作均在授权额度与期限内完成,未出现逾期情况。此举旨在提高募集资金使用效率,为公司及股东获取更多投资回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251011/31697771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2574170159","title":"小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574170159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574170159?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:55","pubTimestamp":1760108115,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,小方制药报收于33.59元,较前一交易日下跌0.3%,最新总市值为53.93亿元。公司近日发布《2025年半年度权益分派实施公告》,宣布本次利润分配方案为每股派发现金红利0.70元(含税)。股权登记日为2025年10月17日,除权(息)日和现金红利发放日均为2025年10月20日。本次权益分派以公司总股本160,559,967股为基数,合计派发现金红利112,391,976.90元。分配对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体A股股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2570061090","title":"小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)","url":"https://stock-news.laohu8.com/highlight/detail?id=2570061090","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570061090?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:13","pubTimestamp":1758787987,"startTime":"0","endTime":"0","summary":"智通财经APP讯,小方制药(603207.SH)发布公告,公司近日与博济医药科技股份有限公司(简称“博济医药”)签署了《技术委托(开发)合同》,博济医药将协助公司完成中药 1.1 类复方侧柏酊新药临床研究及注册,推动其完成临床试验及上市。本次公司与博济医药签署的《技术委托(开发)合同》,是双方基于共同发展战略的一次强强联合,标志着公司在创新药领域布局迈出重要一步。博济医药作为行业领先企业,在研发实力、技术积累和临床资源方面具有显著优势,双方合作将充分发挥各自专长,形成协同效应,有效提升合同产品的研发效率与成功率,为产品后续申报及上市奠定坚实基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","300404","603207","BK0239"],"gpt_icon":0},{"id":"2567813692","title":"每周股票复盘:小方制药(603207)布局创新药并拓展境外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2567813692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567813692?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:58","pubTimestamp":1757797089,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,小方制药报收于34.76元,较上周的34.69元上涨0.2%。本周,小方制药9月9日盘中最高价报36.96元。本周关注点来自机构调研要点:小方制药已开始布局创新药领域,多个项目处于不同研发阶段。来自机构调研要点:复方侧柏酊与复方透骨草溶液为公司研发的中药一类新药。公司目前已经取得了向中国澳门地区出口药品的批准文号并实现在中国澳门地区的销售,未来将逐步开拓其他境外市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","159992","BK1574","06978","603207"],"gpt_icon":0},{"id":"2566978545","title":"小方制药:9月12日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2566978545","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566978545?lang=zh_cn&edition=full","pubTime":"2025-09-12 18:03","pubTimestamp":1757671391,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年9月12日小方制药发布公告称公司于2025年9月12日召开业绩说明会。公司目前已经取得了向中国澳门地区出口药品的批准文号并实现在中国澳门地区的销售,未来将逐步开拓其他境外市场。同时,公司会严格按照监管要求及时披露相关信息。问题3、请问方总,目前小方制药正在进行的创新药研发有哪些,谢谢!公司于2025年9月12日召开2025年半年度业绩说明会,交流情况可登陆上海证券交易所上证路演中心查阅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200029436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2565254330","title":"每周股票复盘:小方制药(603207)将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565254330","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565254330?lang=zh_cn&edition=full","pubTime":"2025-09-07 04:47","pubTimestamp":1757191628,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,小方制药报收于34.69元,较上周的33.92元上涨2.27%。本周关注点公司公告汇总:小方制药将于2025年09月12日召开2025年半年度业绩说明会。说明会结束后,投资者可通过上证路演中心查看会议情况及主要内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2564930831","title":"小方制药:9月12日将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2564930831","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564930831?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:12","pubTimestamp":1756991520,"startTime":"0","endTime":"0","summary":"证券日报网讯9月4日晚间,小方制药发布公告称,公司将于2025年9月12日召开2025年半年度业绩说明会。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-04/doc-infpiwey6671728.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-04/doc-infpiwey6671728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2563834478","title":"每周股票复盘:小方制药(603207)中期分红比例达93.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563834478","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563834478?lang=zh_cn&edition=full","pubTime":"2025-08-31 14:12","pubTimestamp":1756620732,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,小方制药报收于33.92元,较上周的35.2元下跌3.64%。本周,小方制药8月26日盘中最高价报36.02元。公司公告汇总:拟每10股派发现金红利7元(含税),现金分红比例为93.02%。股本股东变化股东户数变动截至2025年6月30日,小方制药股东户数为1.48万户,较3月31日减少4274.0户,减幅22.41%。业绩披露要点财务报告小方制药2025年中报显示,主营收入2.7亿元,同比上升3.06%;归母净利润1.21亿元,同比上升1.69%;扣非净利润1.21亿元,同比上升2.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100004839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2562462122","title":"小方制药(603207.SH)发布半年度业绩,归母净利润1.21亿元,同比增长1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562462122","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562462122?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:43","pubTimestamp":1756122185,"startTime":"0","endTime":"0","summary":"智通财经APP讯,小方制药(603207.SH)披露2025年半年度报告,报告期公司实现营收2.7亿元,同比增长3.06%;归母净利润1.21亿元,同比增长1.69%;扣非净利润1.21亿元,同比增长2.04%;基本每股收益0.75元。公司拟向全体股东每10股派发现金红利7.00元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603207"],"gpt_icon":0},{"id":"2562212013","title":"小方制药(603207)6月30日股东户数1.48万户,较上期减少22.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562212013","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562212013?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:22","pubTimestamp":1756113758,"startTime":"0","endTime":"0","summary":"证券之星消息,近日小方制药披露,截至2025年6月30日公司股东户数为1.48万户,较3月31日减少4274.0户,减幅为22.41%。在化学制药行业个股中,小方制药股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.27万户。从股价来看,2025年3月31日至2025年6月30日,小方制药区间涨幅为3.67%,在此期间股东户数减少4274.0户,减幅为22.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500023641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2561557202","title":"每周股票复盘:小方制药(603207)1440万股限售股将于8月26日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2561557202","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561557202?lang=zh_cn&edition=full","pubTime":"2025-08-24 08:03","pubTimestamp":1755993797,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:小方制药1440万股限售股将于8月26日上市流通公司公告汇总小方制药首次公开发行部分限售股上市流通。公司首次公开发行A股4,000万股,总股本为16,000万股,其中有限售条件流通股120,802,248股,无限售条件流通股39,197,752股。保荐机构认为公司本次限售股份上市流通符合相关法律法规要求,股东已严格履行股份锁定承诺。限售股上市流通明细显示,每位股东各解禁240万股,合计1440万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400002291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2558507018","title":"每周股票复盘:小方制药(603207)因日换手率达20%三度上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2558507018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558507018?lang=zh_cn&edition=full","pubTime":"2025-08-10 03:52","pubTimestamp":1754769133,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘,小方制药报收于35.98元,较上周的36.28元下跌0.83%。本周,小方制药8月4日盘中最高价报39.47元。本周关注点交易信息汇总:小方制药因日换手率达到20%在近5个交易日内第3次登上龙虎榜交易信息汇总沪深交易所2025年8月4日公布的交易公开信息显示,小方制药因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2557375465","title":"小方制药:产品品类丰富剂型全面销售网络覆盖广泛","url":"https://stock-news.laohu8.com/highlight/detail?id=2557375465","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557375465?lang=zh_cn&edition=full","pubTime":"2025-08-06 18:18","pubTimestamp":1754475482,"startTime":"0","endTime":"0","summary":"有投资者向小方制药提问, 贵公司在同行业中的核心优势是什么?公司回答表示,尊敬的投资者您好,公司的主要优势有:产品品类丰富,剂型全面;销售网络覆盖广泛;品牌口碑较好,客户粘性较强等。感谢您的关注","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618232794d3320c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618232794d3320c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2557241773","title":"小方制药:炉甘石洗剂对蚊虫叮咬瘙痒有一定抑制作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2557241773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557241773?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:12","pubTimestamp":1754471532,"startTime":"0","endTime":"0","summary":"证券之星消息,小方制药(603207)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,公司产品炉甘石洗剂对蚊虫叮咬瘙痒有抑制作用吗?广东佛山、广州等地基孔肯雅热病毒爆发以来公司的炉甘石洗剂产品出货量有无明显增加?小方制药回复:尊敬的投资者您好!公司产品炉甘石洗剂对蚊虫叮咬瘙痒是有一定抑制作用的,目前该产品市场需求保持稳定。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600027719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2557324129","title":"小方制药:持续强化自主研发能力并与CRO机构战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2557324129","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557324129?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:12","pubTimestamp":1754471531,"startTime":"0","endTime":"0","summary":"证券之星消息,小方制药(603207)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问:皮肤和消化类是竞争激烈的细分板块,公司研发团队规模小仅23人且研发资金少,请问公司是如何有效推进新产品研发的。小方制药回复:尊敬的投资者您好,小方制药深耕外用药领域三十余年,拥有丰富的研发和生产经验。我们将持续强化自主研发能力,并与优秀的CRO机构开展战略合作,通过优势互补提升研发效率,确保项目高质量推进。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600027716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2556162802","title":"8月4日小方制药(603207)龙虎榜数据:机构净买入1773.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556162802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556162802?lang=zh_cn&edition=full","pubTime":"2025-08-04 17:22","pubTimestamp":1754299335,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年8月4日公布的交易公开信息显示,小方制药因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2025年8月4日收盘,小方制药报收于38.54元,上涨6.23%,换手率31.1%,成交量12.44万手,成交额4.62亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1773.64万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080400023703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761968519859,"stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.0892},{"period":"6month","weight":0.2915},{"period":"1year","weight":0.3429},{"period":"ytd","weight":0.2358}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海小方制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"13323人(较上一季度减少0.25%)","perCapita":"4083股","listingDate":"2024-08-26","address":"上海市奉贤区洪朱路777号","registeredCapital":"16055万元","survey":" 上海小方制药股份有限公司的主营业务是外用药的研发、生产和销售。公司的主要产品是开塞露、甘油灌肠剂、炉甘石洗剂、氧化锌软膏、水杨酸软膏、硫软膏、解痉镇痛酊、冻疮膏、复方薄荷脑软膏、尿素维E乳膏、硼酸洗液、苯扎溴铵溶液、苯扎溴铵酊、复方醋酸地塞米松乳膏、复方苦参水杨酸散、白花油、酮康唑乳膏、复方土槿皮酊。","listedPrice":12.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"小方制药(603207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供小方制药(603207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"小方制药,603207,小方制药股票,小方制药股票老虎,小方制药股票老虎国际,小方制药行情,小方制药股票行情,小方制药股价,小方制药股市,小方制药股票价格,小方制药股票交易,小方制药股票购买,小方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"小方制药(603207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供小方制药(603207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}